These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32486365)

  • 1. Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma.
    Ramzy GM; Koessler T; Ducrey E; McKee T; Ris F; Buchs N; Rubbia-Brandt L; Dietrich PY; Nowak-Sliwinska P
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Testing Techniques: Paving the Way for New Oncology Screening Approaches.
    van Rijt A; Stefanek E; Valente K
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 3D View of Colorectal Cancer Models in Predicting Therapeutic Responses and Resistance.
    Reidy E; Leonard NA; Treacy O; Ryan AE
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33435170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancements in 3D In Vitro Models for Colorectal Cancer.
    Vitale S; Calapà F; Colonna F; Luongo F; Biffoni M; De Maria R; Fiori ME
    Adv Sci (Weinh); 2024 Jul; ():e2405084. PubMed ID: 38962943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psymberin, a marine-derived natural product, induces cancer cell growth arrest and protein translation inhibition.
    Dayanidhi DL; Somarelli JA; Mantyh JB; Rupprecht G; Roghani RS; Vincoff S; Shin I; Zhao Y; Kim SY; McCall S; Hong J; Hsu DS
    Front Med (Lausanne); 2022; 9():999004. PubMed ID: 36743670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Models of Neuroblastoma-Current Status and Perspectives.
    Krawczyk E; Kitlińska J
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical models for development of immune-oncology therapies.
    Wang Y; Shelton SE; Kastrunes G; Barbie DA; Freeman GJ; Marasco WA
    Immuno-oncol Insights; 2022; 3(8):379-398. PubMed ID: 37132013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Revolutionary Roads to Study Cell-Cell Interactions in 3D In Vitro Pancreatic Cancer Models.
    Delle Cave D; Rizzo R; Sainz B; Gigli G; Del Mercato LL; Lonardo E
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33672435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two preclinical tests to evaluate anticancer activity and to help validate drug candidates for clinical trials.
    López-Lázaro M
    Oncoscience; 2015; 2(2):91-8. PubMed ID: 25859551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current status and reflections on 3D
    Zhou B; Sun M; Yang M; Cui W; Yang H
    Hepatobiliary Surg Nutr; 2024 Feb; 13(1):180-183. PubMed ID: 38322201
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug screening model meets cancer organoid technology.
    Liu C; Qin T; Huang Y; Li Y; Chen G; Sun C
    Transl Oncol; 2020 Nov; 13(11):100840. PubMed ID: 32822897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized low-dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment.
    Zoetemelk M; Ramzy GM; Rausch M; Koessler T; van Beijnum JR; Weiss A; Mieville V; Piersma SR; de Haas RR; Delucinge-Vivier C; Andres A; Toso C; Henneman AA; Ragusa S; Petrova TV; Docquier M; McKee TA; Jimenez CR; Daali Y; Griffioen AW; Rubbia-Brandt L; Dietrich PY; Nowak-Sliwinska P
    Mol Oncol; 2020 Nov; 14(11):2894-2919. PubMed ID: 33021054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Throughput Tumor-on-a-Chip Platform to Study Tumor-Stroma Interactions and Drug Pharmacokinetics.
    Chi CW; Lao YH; Ahmed AHR; Benoy EC; Li C; Dereli-Korkut Z; Fu BM; Leong KW; Wang S
    Adv Healthc Mater; 2020 Nov; 9(21):e2000880. PubMed ID: 32965088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases.
    Jian M; Ren L; He G; Lin Q; Tang W; Chen Y; Chen J; Liu T; Ji M; Wei Y; Chang W; Xu J
    J Transl Med; 2020 Jun; 18(1):234. PubMed ID: 32532289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-on-a-Chip for Modeling Immune Checkpoint Inhibitor and Tumor Interactions.
    Jiang X; Ren L; Tebon P; Wang C; Zhou X; Qu M; Zhu J; Ling H; Zhang S; Xue Y; Wu Q; Bandaru P; Lee J; Kim HJ; Ahadian S; Ashammakhi N; Dokmeci MR; Wu J; Gu Z; Sun W; Khademhosseini A
    Small; 2021 Feb; 17(7):e2004282. PubMed ID: 33502118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-derived organoid (PDO) platforms to facilitate clinical decision making.
    Liu L; Yu L; Li Z; Li W; Huang W
    J Transl Med; 2021 Jan; 19(1):40. PubMed ID: 33478472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D Tumor Models and Their Use for the Testing of Immunotherapies.
    Boucherit N; Gorvel L; Olive D
    Front Immunol; 2020; 11():603640. PubMed ID: 33362787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D In Vitro Model (R)evolution: Unveiling Tumor-Stroma Interactions.
    Rodrigues J; Heinrich MA; Teixeira LM; Prakash J
    Trends Cancer; 2021 Mar; 7(3):249-264. PubMed ID: 33218948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spheroids and organoids derived from colorectal cancer as tools for
    Ahmad Zawawi SS; Salleh EA; Musa M
    Explor Target Antitumor Ther; 2024; 5(2):409-431. PubMed ID: 38745769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-derived Organoid Model for Predicting the Chemoresponse in Patients With Colorectal Cancer.
    Yi K; Park SH; Kim DU; Jeon DY; Lee HJ; Song GA; Jo HJ; Baek DH; Han JH; Lee BC
    In Vivo; 2023; 37(4):1751-1759. PubMed ID: 37369516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.